30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

BridgeBio Oncology Therapeutics Inc (BBOT)

The most recent insider trading activity at BridgeBio Oncology Therapeutics Inc. occurred on February 13, 2024. CEO and Chairperson Bihua Chen made multiple significant buy transactions totaling over $24 million. These purchases represent substantial investment by a key executive.
Stock chart
Ticker: BBOT Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Chen Bihua
CEO and Chairperson
3 purchases — total 24,000,000 USD
Buy 13 Feb 2024
Value US$4,191,096.79 | Price 279.69 | Shares 78,056
Buy 13 Feb 2024
Value US$2,394,047.61 | Price 288.68 | Shares 37,098
Buy 13 Feb 2024
Value US$693,600.00 | Price 10.00 | Shares 69,360
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
78,056 -2.7%
279.69
US$4,191,097
78,056 -2.7% 279.69 US$4,191,097
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
37,098 +22.9%
288.68
US$2,394,048
37,098 +22.9% 288.68 US$2,394,048
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
20,375 +39.3%
480.13
US$2,428,918
20,375 +39.3% 480.13 US$2,428,918